# The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia

> **NCT05357183** · — · UNKNOWN · sponsor: **Beijing Ditan Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PEG-IFN

## Key facts

- **NCT ID:** NCT05357183
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2022-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05357183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05357183, "The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05357183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
